ODM guided fluid management is one of six High Impact Innovations listed in the UK NHS 2011 Innovation Health & Wealth report. Based on comprehensive evidence, the document is subtitled Accelerating Adoption and Diffusion in the NHS.
It “sets out an integrated set of measures that together will support the adoption and diffusion of innovation across the NHS.”
It also “sets a delivery agenda that will significantly ramp up the pace and scale of change and innovation.”
In labelling Deltex’s ODM as a High Impact Innovation, the report talks of its comprehensive evidence base and the NICE forecast that ODM guided fluid management has the potential to benefit 800,000 surgical patients by reducing postoperative complications and consequent length of hospital stay.